Four million newborn deaths: is the global research agenda evidence-based?

Area of Science:

• Global Health
• Neonatal Research
• Public Health Policy

Background:

• Neonatal mortality remains a significant global health challenge, with an estimated four million deaths annually, predominantly in low-income countries.
• Despite the high burden, research investment in neonatal health is disproportionately low, particularly in regions like South Asia and sub-Saharan Africa, which bear 75% of the global burden.
• Current research priorities do not fully align with the epidemiological evidence, which highlights the need to focus on the poorest families, critical periods like birth, and major causes such as infections, preterm birth, and asphyxia.

Purpose of the Study:

• To address the critical gap between the burden of neonatal mortality and morbidity and the current research investment and priorities.
• To propose a structured approach for prioritizing newborn research, focusing on a research pipeline from description to scale-up delivery.
• To advocate for the development of a "people pipeline" to build essential research capacity in low-income countries.

Main Methods:

• Review of epidemiological evidence to identify key areas for newborn research prioritization.
• Proposal of a systematic research pipeline model: description, discovery, development, and delivery with scale-up.
• Introduction of a quantitative scoring system for transparent and systematic research prioritization.
• Emphasis on the necessity of a parallel "people pipeline" for capacity building.

Main Results:

• Identified a significant mismatch between the global burden of neonatal mortality/morbidity and the allocation of research funding.
• Highlighted the inadequacy of current research investment in low-income countries, which face the highest mortality rates.
• Proposed a comprehensive framework for research prioritization and capacity building to address global neonatal health inequities.

Conclusions:

• Urgent reallocation of research funding and strategic prioritization are necessary to effectively combat neonatal mortality and morbidity.
• Implementing a structured research pipeline and investing in local research capacity are essential for equitable global health outcomes.
• A concerted, globally coordinated effort is required to ensure that newborn research benefits the most vulnerable populations and reduces preventable deaths.